bioAffinity Technologies (BIAFW) News Today → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free BIAFW Stock Alerts $0.27 -0.12 (-30.55%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 2, 2024 | investorplace.comBIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023April 1, 2024 | finance.yahoo.combioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 5, 2024 | finance.yahoo.combioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungDecember 5, 2023 | finance.yahoo.combioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNovember 28, 2023 | finance.yahoo.combioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNovember 16, 2023 | msn.combioAffinity Technologies files for a $25M mixed shelf offeringOctober 10, 2023 | finance.yahoo.combioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth ConferenceSeptember 19, 2023 | finance.yahoo.combioAffinity Technologies Acquires Laboratory Assets of Precision Pathology ServicesSeptember 15, 2023 | wsj.combioAffinity Technologies Inc. WtAugust 14, 2023 | finance.yahoo.combioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business UpdateJuly 12, 2023 | finance.yahoo.comAMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung CancerJune 15, 2023 | finance.yahoo.combioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics SymposiumMay 22, 2023 | finance.yahoo.combioAffinity Technologies Presents Research Findings at CYTO 2023April 7, 2023 | nasdaq.combioAffinity Technologies, Inc. Rings the Nasdaq Stock Market Closing BellApril 7, 2023 | nasdaq.combioAffinity Technologies, Inc. Rings the Closing BellApril 4, 2023 | bizjournals.comAfter launching IPO, promising SA biotech still chasing profitabilityMarch 24, 2023 | finance.yahoo.combioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023February 13, 2023 | finance.yahoo.combioAffinity Technologies Appoints Julie Anne Overton Director of Corporate CommunicationsJanuary 4, 2023 | marketwatch.comBioAffinity Technologies Shares Rise 8% After Getting Notice to Allow U.S. PatentDecember 1, 2022 | finance.yahoo.combioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO MeetingNovember 14, 2022 | finance.yahoo.combioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 10, 2022 | finance.yahoo.combioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory BoardOctober 25, 2022 | finance.yahoo.combioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and AustraliaOctober 12, 2022 | finance.yahoo.combioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST ConferenceSeptember 28, 2022 | finance.yahoo.combioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6MSeptember 27, 2022 | nasdaq.combioAffinity Technologies, Inc. Warrant (BIAFW)September 14, 2022 | finance.yahoo.combioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide BIAFW Media Mentions By Week BIAFW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIAFW News Sentiment▼1.590.58▲Average Medical News Sentiment BIAFW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIAFW Articles This Week▼30▲BIAFW Articles Average Week Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAFW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: STRRP News Today ACONW News Today DRTSW News Today AONC News Today ARTLW News Today BCTXW News Today BFRGW News Today CCLDP News Today CCLDO News Today CNTG News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIAFW) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithMillionaire investor and Republican donor makes surprising election predictionInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetryCharles Payne Demystifies OptionsUnstoppable ProsperityThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.